Mereo BioPharma Group plc ADR

Historical 13F Holders

Symbol
MREO
CUSIP
589492107
All holders as of
Q1 2025
Type
Equity
Class
SPON ADS
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 11 3.97 M $10.8 M
2025 Q1 101 111 M $250 M
2024 Q4 98 115 M $403 M
2024 Q3 85 106 M $435 M
2024 Q2 86 101 M $363 M
2024 Q1 90 86.8 M $287 M
2023 Q4 73 80.7 M $186 M
2023 Q3 60 70.5 M $90.4 M
2023 Q2 58 64.7 M $84.5 M
2023 Q1 62 61.1 M $43.2 M
2022 Q4 64 61.6 M $46.2 M
2022 Q3 68 68.0 M $58.5 M
2022 Q2 72 74.2 M $82.7 M
2022 Q1 64 89.8 M $99.9 M
2021 Q4 80 92.1 M $146 M
2021 Q3 68 88.4 M $212 M
2021 Q2 80 92.3 M $290 M
2021 Q1 76 97.4 M $325 M
2020 Q4 50 59.9 M $211 M
2020 Q3 29 15.5 M $38.1 M
2020 Q2 25 7.28 M $22.3 M
2020 Q1 15 3.28 M $3.42 M
2019 Q4 15 1.24 M $4.08 M
2019 Q3 17 1.78 M $5.21 M
2019 Q2 19 1.80 M $4.39 M